Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2018 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Characterization of imatinib mesylate formulations distributed in South American countries: Determination of genotoxic impurities by UHPLC-MS/MS and dissolution profile.
Biomed Chromatogr. 2018 Jul;32(7):e4222. doi: 10.1002/bmc.4222. Epub 2018 Apr 6.
Biomed Chromatogr. 2018.
PMID: 29488235
Therefore, in this work an analytical method using UHPLC-MS/MS was developed, validated and applied to characterize IM tablets for two GTIs: N-(2-methyl-5-aminophenyl)-4-(3-pyridyl)-2-pyrimidine amine (Imp. 1), and N-[4-methyl-3-( …
Therefore, in this work an analytical method using UHPLC-MS/MS was developed, validated and applied to characterize IM tablets for two GTIs: …
Nonaqueous capillary electrophoresis of imatinib mesylate and related substances.
Ye L, Huang Y, Li J, Xiang G, Xu L.
Ye L, et al.
J Sep Sci. 2012 Aug;35(16):2108-13. doi: 10.1002/jssc.201200114. Epub 2012 Jul 2.
J Sep Sci. 2012.
PMID: 22753368
In the present study, nonaqueous capillary electrophoretic separation of imatinib mesylate (IM) and related substances, N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinamine (PYA), N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin …
In the present study, nonaqueous capillary electrophoretic separation of imatinib mesylate (IM) and related substances, N-(5-amino-2- …
Item in Clipboard
Cite
Cite